Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy

Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy

Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy


Dr. Otis Vacratsis

University of Windsor

FUNDER: CIHR

GRANT DURATION: 2018-2020

Related Programs:
Nucleus Cores:



Loading...